Viewing Study NCT02311920


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2026-02-20 @ 6:04 PM
Study NCT ID: NCT02311920
Status: COMPLETED
Last Update Posted: 2023-01-10
First Post: 2014-12-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gliosarcoma View
None Supratentorial Glioblastoma View
Keywords: